Browsing Tag
U.S. generics market
3 posts
Breckenridge Pharmaceutical receives FDA approval for dehydrated alcohol injection, strengthening its institutional strategy
Breckenridge secures FDA approval for its generic dehydrated alcohol injection, boosting institutional reach for cardiac therapy. Read more on market strategy.
Lupin launches authorized generic of PENNSAID in US to tap $509m osteoarthritis knee pain market
Lupin launches the authorized generic of PENNSAID in the U.S., targeting the $509M osteoarthritis knee pain market with a proven, cost-effective NSAID solution.
Can Glenmark Pharmaceuticals’ FDA approval for Enstilar Foam generic boost its U.S. dermatology footprint?
Glenmark Pharmaceuticals secures FDA approval for its generic version of Enstilar Foam, aiming to expand its U.S. dermatology market presence.